Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2002 Jul;57(7):586–589. doi: 10.1136/thorax.57.7.586

Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance

I Narang 1, R Ersu 1, N Wilson 1, A Bush 1
PMCID: PMC1746369  PMID: 12096200

Abstract

Background: The levels of exhaled and nasal nitric oxide (eNO and nNO) in groups of patients with inflammatory lung diseases are well documented but the diagnostic use of these measurements in an individual is unknown.

Methods: The levels of nNO and eNO were compared in 31 children with primary ciliary dyskinesia (PCD), 21 with non-CF bronchiectasis (Bx), 17 with cystic fibrosis (CF), 35 with asthma (A), and 53 healthy controls (C) using a chemiluminescence NO analyser. A diagnostic receiver-operator characteristic (ROC) curve for PCD using NO was constructed.

Results: The median (range) levels of nNO in parts per billion (ppb) in PCD, Bx, CF, and C were 60.3 (3.3–920), 533.6 (80–2053), 491.3 (31–1140), and 716 (398–1437), respectively; nNO levels were significantly lower in PCD than in all other groups (p<0.05). The median (range) levels of eNO in ppb in PCD, Bx, CF, A, and C were 2.0 (0.2–5.2), 5.4 (1.0–22.1), 2.6 (0.8–12.9), 10.7 (1.6–46.7), and 4.85 (2.5–18.3), respectively. The difference in eNO levels in PCD reached significance (p<0.05) when compared with those in Bx, A and C but not when compared with CF. Using the ROC curve, nNO of 250 ppb showed a sensitivity of 97% and a specificity of 90% for the diagnosis of PCD.

Conclusions: eNO and nNO cannot be used diagnostically to distinguish between most respiratory diseases. However, nNO in particular is a quick and useful diagnostic marker which may be used to screen patients with a clinical suspicion of PCD.

Full Text

The Full Text of this article is available as a PDF (113.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balfour-Lynn I. M., Laverty A., Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child. 1996 Oct;75(4):319–322. doi: 10.1136/adc.75.4.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baraldi E., Azzolin N. M., Zanconato S., Dario C., Zacchello F. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J Pediatr. 1997 Sep;131(3):381–385. doi: 10.1016/s0022-3476(97)80062-5. [DOI] [PubMed] [Google Scholar]
  3. Bush A., Cole P., Hariri M., Mackay I., Phillips G., O'Callaghan C., Wilson R., Warner J. O. Primary ciliary dyskinesia: diagnosis and standards of care. Eur Respir J. 1998 Oct;12(4):982–988. doi: 10.1183/09031936.98.12040982. [DOI] [PubMed] [Google Scholar]
  4. Byrnes C. A., Dinarevic S., Busst C. A., Shinebourne E. A., Bush A. Effect of measurement conditions on measured levels of peak exhaled nitric oxide. Thorax. 1997 Aug;52(8):697–701. doi: 10.1136/thx.52.8.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Byrnes C. A., Dinarevic S., Shinebourne E. A., Barnes P. J., Bush A. Exhaled nitric oxide measurements in normal and asthmatic children. Pediatr Pulmonol. 1997 Nov;24(5):312–318. doi: 10.1002/(sici)1099-0496(199711)24:5<312::aid-ppul2>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  6. Franklin P. J., Taplin R., Stick S. M. A community study of exhaled nitric oxide in healthy children. Am J Respir Crit Care Med. 1999 Jan;159(1):69–73. doi: 10.1164/ajrccm.159.1.9804134. [DOI] [PubMed] [Google Scholar]
  7. Grasemann H., Ioannidis I., Tomkiewicz R. P., de Groot H., Rubin B. K., Ratjen F. Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child. 1998 Jan;78(1):49–53. doi: 10.1136/adc.78.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jain B., Rubinstein I., Robbins R. A., Leise K. L., Sisson J. H. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun. 1993 Feb 26;191(1):83–88. doi: 10.1006/bbrc.1993.1187. [DOI] [PubMed] [Google Scholar]
  9. Karadag B., James A. J., Gültekin E., Wilson N. M., Bush A. Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia. Eur Respir J. 1999 Jun;13(6):1402–1405. doi: 10.1183/09031936.99.13614069. [DOI] [PubMed] [Google Scholar]
  10. Kharitonov S. A., Barnes P. J. Nasal contribution to exhaled nitric oxide during exhalation against resistance or during breath holding. Thorax. 1997 Jun;52(6):540–544. doi: 10.1136/thx.52.6.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kharitonov S. A., Wells A. U., O'Connor B. J., Cole P. J., Hansell D. M., Logan-Sinclair R. B., Barnes P. J. Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med. 1995 Jun;151(6):1889–1893. doi: 10.1164/ajrccm.151.6.7767536. [DOI] [PubMed] [Google Scholar]
  12. Kharitonov S., Alving K., Barnes P. J. Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J. 1997 Jul;10(7):1683–1693. doi: 10.1183/09031936.97.10071683. [DOI] [PubMed] [Google Scholar]
  13. Lundberg J. O., Weitzberg E., Nordvall S. L., Kuylenstierna R., Lundberg J. M., Alving K. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur Respir J. 1994 Aug;7(8):1501–1504. doi: 10.1183/09031936.94.07081501. [DOI] [PubMed] [Google Scholar]
  14. Nakano H., Ide H., Imada M., Osanai S., Takahashi T., Kikuchi K., Iwamoto J. Reduced nasal nitric oxide in diffuse panbronchiolitis. Am J Respir Crit Care Med. 2000 Dec;162(6):2218–2220. doi: 10.1164/ajrccm.162.6.2003051. [DOI] [PubMed] [Google Scholar]
  15. Robbins R. A., Barnes P. J., Springall D. R., Warren J. B., Kwon O. J., Buttery L. D., Wilson A. J., Geller D. A., Polak J. M. Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun. 1994 Aug 30;203(1):209–218. doi: 10.1006/bbrc.1994.2169. [DOI] [PubMed] [Google Scholar]
  16. Warner J. O., Götz M., Landau L. I., Levison H., Milner A. D., Pedersen S., Silverman M. Management of asthma: a consensus statement. Arch Dis Child. 1989 Jul;64(7):1065–1079. doi: 10.1136/adc.64.7.1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Whittle B. J. Nitric oxide in physiology and pathology. Histochem J. 1995 Oct;27(10):727–737. [PubMed] [Google Scholar]
  18. Wilson N. M., James A., Uasuf C., Payne D. N., Hablas H., Agrofioti C., Bush A. Asthma severity and inflammation markers in children. Pediatr Allergy Immunol. 2001 Jun;12(3):125–132. doi: 10.1034/j.1399-3038.2001.012003125.x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES